Literature DB >> 17570103

CCR5 inhibitors: promising yet challenging.

Bonaventura Clotet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17570103     DOI： 10.1086/518799

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.

Authors:  Zhaohui Su; Roy M Gulick; Amy Krambrink; Eoin Coakley; Michael D Hughes; Dong Han; Charles Flexner; Timothy J Wilkin; Paul R Skolnik; Wayne L Greaves; Daniel R Kuritzkes; Jacqueline D Reeves
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

2.  A Short-Term Assessment of Nascent HIV-1 Transmission Clusters Among Newly Diagnosed Individuals Using Envelope Sequence-Based Phylogenetic Analyses.

Authors:  Alexis Kafando; Bouchra Serhir; Florence Doualla-Bell; Eric Fournier; Mohamed Ndongo Sangaré; Christine Martineau; Mohamed Sylla; Annie Chamberland; Mohamed El-Far; Hugues Charest; Cécile L Tremblay
Journal:  AIDS Res Hum Retroviruses       Date:  2019-09-10       Impact factor: 2.205

3.  Identifying CCR5 coreceptor populations permissive for HIV-1 entry and productive infection: implications for in vivo studies.

Authors:  Matthew Weichseldorfer; Yutaka Tagaya; Marvin Reitz; Anthony L DeVico; Olga S Latinovic
Journal:  J Transl Med       Date:  2022-01-24       Impact factor: 5.531

4.  microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury.

Authors:  Jian-Song Zhang; Pin-Pin Hou; Shuai Shao; Anatol Manaenko; Zhi-Peng Xiao; Yan Chen; Bing Zhao; Feng Jia; Xiao-Hua Zhang; Qi-Yong Mei; Qin Hu
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.